PD‐L1 expression on tumor or stromal cells of nodal cytotoxic T‐cell lymphoma: A clinicopathological study of 50 cases

Inhibitors of programmed cell‐death 1 (PD‐1) and programmed cell‐death ligand 1 (PD‐L1) have revolutionized cancer therapy. Nodal cytotoxic T‐cell lymphoma (CTL) is characterized by a poorer prognosis compared to nodal non‐CTLs. Here we investigated PD‐L1 expression in 50 nodal CTL patients, with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Daisuke, Shimada, Kazuyuki, Kohno, Kei, Kogure, Yasunori, Kataoka, Keisuke, Takahara, Taishi, Suzuki, Yuka, Satou, Akira, Sakakibara, Ayako, Nakamura, Shigeo, Asano, Naoko, Kato, Seiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496983/
https://www.ncbi.nlm.nih.gov/pubmed/32424876
http://dx.doi.org/10.1111/pin.12950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496983/
https://www.ncbi.nlm.nih.gov/pubmed/32424876
http://dx.doi.org/10.1111/pin.12950

Ejemplares similares